Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Li, Xiaoye, Zhang, Xiaochun, Jin, Qinchun, Xue, Ying, Lu, Wenjing, Ge, Junbo, Zhou, Daxin, Lv, Qianzhou
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2021
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8249758/
https://ncbi.nlm.nih.gov/pubmed/34220493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.614762
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk